US 10912770
Targeting AMP deaminase 2 for ameliorating craving for sugar and other substances
granted A61KA61K31/426A61K31/4418
Quick answer
US patent 10912770 (Targeting AMP deaminase 2 for ameliorating craving for sugar and other substances) held by The Regents of the University of Colorado, a Body Corporate expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/426, A61K31/4418, A61K31/455, A61K31/472